Biohit Oyj B-shares Subscribed with Stock Options II 2013
Modern colorectal cancer screening test on the market from Finland
AACC American Association for Clinical Chemistry
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”.
Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.